Cardio Diagnostics Holdings, Inc.

NasdaqCM:CDIO Stock Report

Market Cap: US$35.3m

Cardio Diagnostics Holdings Management

Management criteria checks 3/4

Cardio Diagnostics Holdings' CEO is Meesha Dogan, appointed in May 2021, has a tenure of 3.67 years. total yearly compensation is $648.89K, comprised of 46.2% salary and 53.8% bonuses, including company stock and options. directly owns 4.02% of the company’s shares, worth $1.42M. The average tenure of the management team and the board of directors is 3.2 years and 2.3 years respectively.

Key information

Meesha Dogan

Chief executive officer

US$648.9k

Total compensation

CEO salary percentage46.2%
CEO tenure3.7yrs
CEO ownership4.0%
Management average tenure3.2yrs
Board average tenure2.3yrs

Recent management updates

Recent updates

We Think Cardio Diagnostics Holdings (NASDAQ:CDIO) Can Afford To Drive Business Growth

Mar 01
We Think Cardio Diagnostics Holdings (NASDAQ:CDIO) Can Afford To Drive Business Growth

Companies Like Cardio Diagnostics Holdings (NASDAQ:CDIO) Are In A Position To Invest In Growth

Nov 02
Companies Like Cardio Diagnostics Holdings (NASDAQ:CDIO) Are In A Position To Invest In Growth

CEO Compensation Analysis

How has Meesha Dogan's remuneration changed compared to Cardio Diagnostics Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$8m

Jun 30 2024n/an/a

-US$9m

Mar 31 2024n/an/a

-US$12m

Dec 31 2023US$649kUS$300k

-US$8m

Sep 30 2023n/an/a

-US$9m

Jun 30 2023n/an/a

-US$9m

Mar 31 2023n/an/a

-US$5m

Dec 31 2022US$5mUS$175k

-US$5m

Sep 30 2022n/an/a

-US$2m

Jun 30 2022n/an/a

-US$2m

Mar 31 2022n/an/a

-US$770k

Dec 31 2021US$81kUS$75k

-US$620k

Compensation vs Market: Meesha's total compensation ($USD648.89K) is about average for companies of similar size in the US market ($USD649.07K).

Compensation vs Earnings: Meesha's compensation has been consistent with company performance over the past year.


CEO

Meesha Dogan (35 yo)

3.7yrs

Tenure

US$648,893

Compensation

Dr. Meeshanthini V. Dogan, Ph D., also known as Meesha, is Co-Founder at Cardio Diagnostics Holdings, Inc. She serves as Chief Executive Officer and Director since May 19, 2021 at Cardio Diagnostics Holdin...


Leadership Team

NamePositionTenureCompensationOwnership
Meeshanthini Dogan
Co-Founder3.7yrsUS$648.89k4.02%
$ 1.4m
Elisa Luqman
Chief Financial Officer3.8yrsUS$347.47k0.14%
$ 50.6k
Robert Philibert
Co-Founderno datano data4.13%
$ 1.5m
Timur Dogan
Chief Technology Officer2.7yrsno data0.39%
$ 138.4k
Khullani Abdullahi
Vice President of Revenue & Strategy2.7yrsno data0.036%
$ 12.7k

3.2yrs

Average Tenure

40yo

Average Age

Experienced Management: CDIO's management team is considered experienced (3.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Meeshanthini Dogan
Co-Founder3.7yrsUS$648.89k4.02%
$ 1.4m
Robert Philibert
Co-Founder3.7yrsno data4.13%
$ 1.5m
Warren Hosseinion
Non-Executive Chairman2.3yrsUS$455.29k0.29%
$ 101.4k
Paul Burton
Independent Director1.1yrsno data0.022%
$ 7.7k
James Intrater
Independent Director2.3yrsUS$50.00k0.18%
$ 62.6k
Wendy Betts
Independent Directorless than a yearno datano data
Peter Fung
Independent Directorless than a yearno datano data

2.3yrs

Average Tenure

57yo

Average Age

Experienced Board: CDIO's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 22:40
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cardio Diagnostics Holdings, Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bruce JacksonBenchmark Company
Carl ByrnesNorthland Capital Markets